AJP - Endocrinology and Metabolism, Vol 250, Issue 1 94-E99, Copyright © 1986 by American Physiological Society

ARTICLES

Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy

P. A. Low, J. D. Schmelzer, K. K. Ward and J. K. Yao

The cardinal electrophysiological abnormalities in experimental diabetic (EDN) and experimental galactose (EGN) neuropathy, models in which endoneurial hypoxia has been demonstrated, are a slowing in nerve conduction velocity (NCV) and a resistance to ischemic conduction block (RICB). These electrophysiological abnormalities are also present in human diabetic neuropathy, where microangiopathy has been demonstrated to be more severe than in EDN so that endoneurial hypoxia is also likely to be present. We examined the effects of endoneurial hypoxia per se on normal nerves. In rats subjected to chronic hypoxia (10% O2) for up to 10 wk, the two electrophysiological abnormalities had developed by 4 wk and were very similar in degree to those seen in EDN and EGN. These abnormalities occurred in the absence of hyperglycemia, nerve sorbitol accumulation, or myoinositol reduction. Resting O2 consumption was reduced, the percent increase in nerve lactate under anoxic stress was increased, and nerve free sugars were normal. Hexokinase and phosphofructokinase activities were not altered substantially when studied under conditions of O2 excess. These findings indicate that hypoxia per se will cause conduction slowing and suggest that the hypoxic nerve develops RICB because of a reduced energy requirement and an increased efficiency of anaerobic glycolysis, but without major changes in the activity of its controlling glycolytic enzymes.

This article has been cited by other articles:

				L L Teunissen, H Franssen, J H J Wokke, Y van der Graaf, W H J P Linssen, J D Banga, D M Laman, and N C Notermans Is cardiovascular disease a risk factor in the development of axonal polyneuropathy? J. Neurol. Neurosurg. Psychiatry, May 1, 2002; 72(5): 590 - 595. [Abstract] [Full Text] [PDF]

				P Ludemann, R Dziewas, P Soros, S Happe, and A Frese Axonal polyneuropathy in obstructive sleep apnoea J. Neurol. Neurosurg. Psychiatry, May 1, 2001; 70(5): 685 - 687. [Abstract] [Full Text] [PDF]

				I. G. OBROSOVA, C. VAN HUYSEN, L. FATHALLAH, X. CAO, M. J. STEVENS, and D. A. GREENE Evaluation of {alpha}1-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense FASEB J, August 1, 2000; 14(11): 1548 - 1558. [Abstract] [Full Text]

				P. MAYER, M. DEMATTEIS, J. L. PÉPIN, B. WUYAM, D. VEALE, A. VILA, and P. LÉVY Peripheral Neuropathy in Sleep Apnea . A Tissue Marker of the Severity of Nocturnal Desaturation Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 213 - 219. [Abstract] [Full Text]